Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million Series B with Premier Investors
Advancing multiple programs across Crohn’s disease, ulcerative colitis, rheumatoid arthritis, and idiopathic pulmonary fibrosis; 10+ clinical readouts expected... Read more.
Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
Strategic collaboration expands taletrectinib global reach with a leading oncology partner Eisai will receive exclusive development, registration and commercialization... Read more.
MakeMyTrip Limited to Report Fiscal 2026 Third Quarter Financial & Operating Results on January 21, 2026
GURUGRAM, India & NEW YORK–(BUSINESS WIRE)–$MMYT #Financialresults–MakeMyTrip Limited (Nasdaq: MMYT) plans to report its fiscal 2026 third... Read more.
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands
Cellares’ new IDMO Smart Factory in Leiden, Netherlands, expands commercial-scale manufacturing capacity for European cell therapy patient populations through... Read more.
SelectQuote Secures New $415 Million Credit Facility Comprised of $325 Million Term Loan with Pathlight Capital Alongside $90 Million Revolving Credit Facility with UMB Bank
New Agreement Significantly Extends Debt Maturity and Enhances Operational Flexibility OVERLAND PARK, Kan.–(BUSINESS WIRE)–SelectQuote, Inc. (NYSE: SLQT)... Read more.
Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO
New investors include Pfizer Ventures and Apricot Capital with proceeds to advance pipeline and global expansion Vibrant’s lead solid tumor program, VIB305, is... Read more.
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
– Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 million – – Announces Chief Financial... Read more.
FIS Launches Industry-First Offering Enabling Banks to Lead and Scale in Agentic Commerce
First-of-its-kind capabilities will help FIS bank clients remain top of wallet with cardholders by enabling agentic commerce while enhancing fraud protection. FIS... Read more.
Independence Power Holdings, Inc. Completes Business Combination/Reverse Merger with TriUnity Business Services; Addresses Permian Basin Power Shortfall with Software-Driven Microgrids
MENTONE, Texas–(BUSINESS WIRE)–Independence Power Holdings, Inc. (OTC ticker: ITXP) (“Independence Power” or the “Company”) today announced its... Read more.
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
Phase 1/2a ELIMINATE-B trial for PBGENE-HBV ongoing across multiple dosing cohorts; Data updates expected at medical conferences in 2026 PBGENE-DMD expecting IND... Read more.